Therefore, it is plausible that LC patients experience more inflammation-prone events due to the persistence of elevated IgG3, while the control group having higher levels of the less inflammatory IgG4 is comparatively protected. Here, IGHG3 is linked to laryngotracheoesophageal cleft.